Medicare, Zepbound and obstructive sleep apnea

The government-funded insurance plan will now pay for the drug for patients with obstructive sleep apnea, a condition that ...
The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for health insurers and ...
This approval could expand access to the medication, allowing Zepbound to join Novo Nordisk’s (NVO) competing weight-loss drug Wegovy in being covered by Medicare. “Nearly half of clinical ...